nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Carboplatin/Etoposide/Paclitaxel in the Treatment of Patients with Extensive Small-Cell Lung Cancer
|
Niell, Harvey B. |
|
2001 |
2 |
3 |
p. 204-209 6 p. |
artikel |
2 |
Commentary on “Effectiveness of Radiation Therapy on Non–Small-Cell Lung Cancer”
|
Murray, Nevin |
|
2001 |
2 |
3 |
p. 193-194 2 p. |
artikel |
3 |
Commentary on “Effectiveness of Radiation Therapy on Non–Small-Cell Lung Cancer”
|
Bonner, James A. |
|
2001 |
2 |
3 |
p. 191-192 2 p. |
artikel |
4 |
Effectiveness of Radiation Therapy on Non–Small-Cell Lung Cancer
|
Gressen, Eric L. |
|
2001 |
2 |
3 |
p. 182-190 9 p. |
artikel |
5 |
Effect of HER2/neu Expression on Survival in Non–Small-Cell Lung Cancer
|
Korrapati, Vijaya |
|
2001 |
2 |
3 |
p. 216-219 4 p. |
artikel |
6 |
2000 Highlights From: 25th European Society for Medcial Oncology Congress; Hamburg, Germany October 13–17, 2000
|
D'Orazio, Amy |
|
2001 |
2 |
3 |
p. 173-177 5 p. |
artikel |
7 |
Irinotecan/Cisplatin versus Vindesine/Cisplatin versus Irinotecan Alone in Advanced Non–Small-Cell Lung Cancer
|
|
|
2001 |
2 |
3 |
p. 180-181 2 p. |
artikel |
8 |
Phase II and Phase III Trials: Docetaxel/Irinotecan versus Docetaxel/Cisplatin in Advanced Non–Small-Cell Lung Cancer (WJTOG 9803)
|
|
|
2001 |
2 |
3 |
p. 178-179 2 p. |
artikel |
9 |
Placebo-Controlled Trial of Bexarotene, a Retinoid X Receptor Agonist, as Maintenance Therapy for Patients Treated with Chemotherapy for Advanced Non–Small-Cell Lung Cancer
|
Rizvi, Naiyer |
|
2001 |
2 |
3 |
p. 210-215 6 p. |
artikel |
10 |
Potential Clinical Application of Antioncogene Ribozymes for Human Lung Cancer
|
Tong, Alex W. |
|
2001 |
2 |
3 |
p. 220-226 7 p. |
artikel |
11 |
Radiosurgery and Radiotherapy for Non–Small-Cell Lung Cancer Metastatic to Brain
|
Tsao, May N. |
|
2001 |
2 |
3 |
p. 197-203 7 p. |
artikel |
12 |
The Role of Positron Emission Tomography in Evaluating Mediastinal Lymph Node Metastases in Non–Small-Cell Lung Cancer
|
Luketich, James D. |
|
2001 |
2 |
3 |
p. 229-233 5 p. |
artikel |